| RS61740138 |
ZNF513
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS61740165 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 2, primary |
| RS61740212 |
CRB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CRB2-related disorder |
| RS61740250 |
IFT172
|
Health Risk |
Conflicting classifications of pathogenicity |
Short-rib thoracic dysplasia 10 with or without polydactyly, Retinitis pigmentosa 71 |
| RS61740253 |
RUSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 61 |
| RS61740284 |
CYP2U1
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS61740289 |
RDH12
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 13, Retinal dystrophy |
| RS61740381 |
EFEMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa, autosomal recessive |
| RS61740429 |
NMNAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 9, Inborn genetic diseases |
| RS61740517 |
LRP5
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta, 8 conditions |
| RS61740537 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS61740622 |
IL17RD
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism, Hypogonadotropic hypogonadism |
| RS61740738 |
CEP164
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis 15, Inborn genetic diseases |
| RS61740824 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS61740825 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS61741025 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, AMPD1-related disorder |
| RS61741123 |
SCN1A
|
Health Risk |
Pathogenic |
Severe myoclonic epilepsy in infancy, Familial hemiplegic migraine |
| RS61741147 |
AIP
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Acroleukopathy |
| RS61741164 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS61741347 |
NLRP12
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cold autoinflammatory syndrome 2, Familial cold autoinflammatory syndrome 2 |
| RS61741547 |
NIN
|
Health Risk |
Conflicting classifications of pathogenicity |
NIN-related disorder, NIN-related disorder |
| RS61741581 |
DDB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Xeroderma pigmentosum, group E |
| RS61741609 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS61741781 |
DSE
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, musculocontractural type 2 |
| RS61741838 |
ATP13A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Kufor-Rakeb syndrome, Autosomal recessive spastic paraplegia type 78 |
| RS61741974 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS61741984 |
GLIS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61742006 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61742045 |
EARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome, Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome |
| RS61742059 |
TRIP11
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IA |
| RS61742096 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS61742191 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS61742258 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS61742271 |
ZYX
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61742313 |
TELO2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61742323 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS61742331 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS61742381 |
RPGRIP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS61742428 |
ZNF513
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 58, Retinitis pigmentosa |
| RS61742726 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, infantile |
| RS61742739 |
SLC5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial renal glucosuria, SLC5A2-related disorder |
| RS61742789 |
MUC5B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61742801 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS61742851 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHARGE syndrome |
| RS61742871 |
LRP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cenani-Lenz syndactyly syndrome, Congenital myasthenic syndrome 17 |
| RS61742872 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS61742914 |
PCDH19
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 9 |
| RS61742937 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Spinocerebellar ataxia |
| RS61742990 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS61743014 |
TANC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61743088 |
ROS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Abnormal brain morphology, Ovarian serous cystadenocarcinoma |
| RS61743169 |
SLC22A12
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC22A12-related disorder, SLC22A12-related disorder |
| RS61743239 |
ITK
|
Health Risk |
Conflicting classifications of pathogenicity |
Lymphoproliferative syndrome 1, ITK-related disorder |
| RS61743240 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61743299 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS61743313 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS61743394 |
POP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, POP1-related disorder |
| RS61743502 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypercholesterolemia, Hypercholesterolemia |
| RS61743512 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS61743560 |
CNOT3
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian serous cystadenocarcinoma, Intellectual developmental disorder with speech delay |
| RS61743618 |
WHRN
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2D, Autosomal recessive nonsyndromic hearing loss 31 |
| RS61743653 |
TCN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Transcobalamin II deficiency, Transcobalamin II deficiency |
| RS61743674 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lethal Kniest-like syndrome, Schwartz-Jampel syndrome |
| RS61743702 |
F12
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61743749 |
ACACA
|
Health Risk |
Conflicting classifications of pathogenicity |
ACACA-related disorder, ACACA-related disorder |
| RS61743849 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Inborn genetic diseases |
| RS61743881 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
CCDC88C-related disorder, CCDC88C-related disorder |
| RS61744000 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Uterine corpus endometrial carcinoma |
| RS61744094 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61744141 |
TTC28
|
Health Risk |
Conflicting classifications of pathogenicity |
TTC28-related disorder, TTC28-related disorder |
| RS61744153 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS61744288 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS61744348 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS61744386 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS61744444 |
ADGRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bilateral frontoparietal polymicrogyria, Inborn genetic diseases |
| RS61744448 |
IFT122
|
Health Risk |
Conflicting classifications of pathogenicity |
Cranioectodermal dysplasia 1, Cranioectodermal dysplasia 1 |
| RS61744449 |
SETD1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Epilepsy, early-onset |
| RS61744480 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, ADGRV1-related disorder |
| RS61744521 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS61744606 |
SH3KBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61744648 |
FANCM
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS61744666 |
SIL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marinesco-Sjögren syndrome, Marinesco-Sjögren syndrome |
| RS61744855 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, familial |
| RS61745086 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS61745095 |
KIAA0586
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 23, Short-rib thoracic dysplasia 14 with polydactyly |
| RS61745113 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypercholesterolemia |
| RS61745147 |
CYB5R3
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of cytochrome-b5 reductase, Deficiency of cytochrome-b5 reductase |
| RS61745150 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Inborn genetic diseases |
| RS61745161 |
UNC80
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61745355 |
TNXB
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Vesicoureteral reflux 8 |
| RS61745409 |
TSHR
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hyperthyroidism due to mutations in TSH receptor, Hypothyroidism due to TSH receptor mutations |
| RS61745496 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2C, Inborn genetic diseases |
| RS61745503 |
ALS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile-onset ascending hereditary spastic paralysis, Amyotrophic lateral sclerosis type 2 |
| RS61745524 |
CYP4V2
|
Health Risk |
Conflicting classifications of pathogenicity |
Corneal dystrophy, Bietti crystalline corneoretinal dystrophy |
| RS61745528 |
SCUBE3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61745540 |
DCLRE1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to DCLRE1C deficiency, Histiocytic medullary reticulosis |
| RS61745556 |
PKHD1L1
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 124, Autosomal recessive nonsyndromic hearing loss 124 |
| RS61745591 |
PPCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, dilated |
| RS61745604 |
CCDC88C
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS61745612 |
FREM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |